Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 17.190
- -0.100-0.58%
Close Feb 14 16:00 ET
5.75BMarket Cap193.15P/E (TTM)
17.855High17.000Low24.09KVolume17.000Open17.290Pre Close414.74KTurnover0.14%Turnover Ratio1910.00P/E (Static)334.72MShares19.99052wk High22.41P/B292.23MFloat Cap14.01052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM4.95%Amplitude14.010Historical Low17.219Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Telix Pharmaceuticals Stock Forum
Clinical Trial Success: Telix's Revolutionary Prostate Cancer Treatment Shows Promising Results
Inside Telix's Strategic $45M ImaginAb Acquisition: Next-Gen Cancer Treatment Pipeline Secured
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Positive
Strategic acquisition of next-generation therapeutic pipeline and technology platform
Access to state-of-the-art California research facility and expert team
Enhanced in-house capabilities in antibody engineering
Technology enables highly specific cancer targeting with improved efficiency
Potential for expansion into new therapy areas
Negative
Significant upf...
No comment yet